Quick Answer
Nuvation Bio Inc. reported Total Revenue of $62.90 million for fiscal year 2025.
Nuvation Bio Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $62.90M | +699.0% |
| 2024 | $7.87M | — |
| 2023 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $13.12M | +1704.7% | +171.5% |
| June 30, 2025 | $4.83M | +236.8% | +56.7% |
| March 31, 2025 | $3.08M | — | +324.2% |
| September 30, 2024 | $727.0K | — | -49.3% |
| June 30, 2024 | $1.44M | — | — |
| March 31, 2024 | $0.00 | — | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | — |
- Nuvation Bio Inc. showed an increase of +699.0% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from Nuvation Bio Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: